Schizophrenia spectrum disorders (SSD) are severe mental health conditions marked by cognitive impairments, poor functional outcomes, reduced quality of life, high internalized stigma, and low life engagement....
Preventing Relapse and Hospitalization in Schizophrenia
The prevention of relapse and hospitalization in schizophrenia is a significant public health challenge. Antipsychotic medications reduce relapse risk, with...
Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
A review of 22 randomized controlled trials involving 1500 patients with schizophrenia spectrum disorder explored the use of mindfulness-based interventions...
Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Emerging Treatments for Schizophrenia: Addressing Gaps in Symptom Management and Adherence Challenges
Schizophrenia is a severe condition treated primarily with dopamine-modulating antipsychotics, which mainly address positive symptoms but often fail to manage...
Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Predictors of Medication Response in Treatment-Resistant Schizophrenia
A study aimed to identify predictors of medication response in treatment-resistant schizophrenia (TRS) by analyzing baseline patient and study characteristics...
Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Transcranial Direct Current Stimulation: A Promising Treatment for Schizophrenia
Transcranial direct current stimulation (tDCS) is a promising treatment for schizophrenia, improving clinical symptoms, cognitive function, and neuroplasticity. Recent studies...
Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Patient Preferences in Schizophrenia: Study Insights
Understanding patient preferences for long-acting injectable (LAI) versus oral antipsychotics can help reduce barriers to LAI use in schizophrenia. Post...
Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
